Page last updated: 2024-08-21

benzoxazoles and Glomerulonephritis, IGA

benzoxazoles has been researched along with Glomerulonephritis, IGA in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chihara, A; Nakamura, T; Node, K; Sato, E; Tanaka, A	1

Other Studies

1 other study(ies) available for benzoxazoles and Glomerulonephritis, IGA

Article	Year
Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia. CEN case reports, 2020, Volume: 9, Issue:2 Topics: Adult; Atherosclerosis; Benzoxazoles; Butyrates; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Hypertriglyceridemia; Male; Middle Aged; PPAR alpha; Proteins; Proteinuria; Renal Insufficiency; Treatment Outcome	2020

Article

Year

Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia.

CEN case reports, 2020, Volume: 9, Issue:2

Topics: Adult; Atherosclerosis; Benzoxazoles; Butyrates; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Hypertriglyceridemia; Male; Middle Aged; PPAR alpha; Proteins; Proteinuria; Renal Insufficiency; Treatment Outcome

2020